The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,926.00
Bid: 11,924.00
Ask: 11,926.00
Change: 574.00 (5.06%)
Spread: 2.00 (0.017%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: UK's Sunak To Unveil GBP2 Billion Unemployment Scheme

Wed, 08th Jul 2020 07:54

(Alliance News) - UK Chancellor Rishi Sunak will on Wednesday announce a GBP2 billion scheme aimed at alleviating youth unemployment by subsidising work placements when he sets out his coronavirus recovery package.

A three-point plan to boost the ailing economy by helping job creation will include a plan to help pay for six-month placements for some under-25s facing long-term unemployment.

Sunak will set out the measures in his summer economic update in the House of Commons, as he faces pressure to assist those who are most at vulnerable to the effects of a financial crisis.

Sunak will also offer an immediate stamp duty "holiday" to temporarily exempt the tax on the first GBP500,000 of homes purchased in England and Northern Ireland, according to unconfirmed reports.

The Treasury acknowledged that young people are more likely to be furloughed under the job retention scheme which is being wound up and is due to end in October.

So a "kickstart scheme" hoped by the Treasury to create hundreds of thousands of jobs will be unveiled for 16 to 24-year-olds who are claiming Universal Credit and at risk of long-term employment.

Government funding would cover 100% of the minimum wage for 25 hours a week in the scheme that will be open to all employers across Great Britain, with bosses able to top up wages.

Ahead of the announcement, Sunak said: "Young people bear the brunt of most economic crises, but they are at particular risk this time because they work in the sectors disproportionately hit by the pandemic.

"We also know that youth unemployment has a long-term impact on jobs and wages and we don't want to see that happen to this generation.

"So we've got a bold plan to protect, support and create jobs – a plan for jobs."

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.9% at 6,133.00

----------

Hang Seng: up 0.7% at 26,151.65

Nikkei 225: closed down 0.8% at 22,438.65

DJIA: closed down 396.85 points, 1.5%, at 25,890.18

S&P 500: closed down 1.1% at 3,145.32

----------

GBP: down at USD1.2551 (USD1.2586)

EUR: down at USD1.1273 (USD1.1297)

Gold: up at USD1,794.20 per ounce (USD1,793.61)

Oil (Brent): down at USD42.86 a barrel (USD43.26)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Wednesday's Key Economic Events still to come

UK Chancellor Rishi Sunak delivers summer economic update

0700 EDT US MBA Weekly Mortgage Applications Survey

0815 EDT Canada Housing Starts

1030 EDT US EIA Weekly Petroleum Status Report

1500 EDT US Consumer Credit

----------

Britain's economy will not recover to pre-pandemic levels until 2024 even without a second wave, according to research. A report by accountants BDO and the Centre for Economics and Business Research forecasts gross domestic product will fall 11% this year – but only if there is no large-scale second wave of coronavirus or another national lockdown. It warns that another peak in the pandemic and lockdown would send Britain's GDP tumbling 19% this year and see exports fall by 23%. The study cautions that the "dual threat" of the pandemic and Brexit to international trade will hammer the UK's export industry in either scenario. With no second lockdown, exports will still fall by 19% this year, which will weigh on economic growth, the study found. Exports may recover a little in 2021 before stagnating, according to the report.

----------

Japan's current account surplus was nearly ten times higher in May from the previous month, data from the country's Ministry of Finance showed Wednesday. Japan's current account surplus rose to JPY11.768 trillion, about USD109 billion, from JPY2.627 trillion in April. The dramatic rise was boosted by a sharp contraction in the country's Goods & Services deficit to JPY6.493 trillion from JPY15.967 trillion the previous month. May's surplus was ahead of consensus estimates, according to FXStreet, of a JPY1.088 trillion surplus. The surplus, however, was lower from May 2019, when it stood at JPY16.311 trillion. Exports slipped in May to JPY41.979 trillion from JPY49.090 trillion in April. Imports also slipped, falling to JPY47.547 trillion from JPY58.756 trillion. As a result, Japan recorded a trade deficit of JPY556.8 billion, which is lower than April's deficit of JPY966.6 billion.

----------

German Chancellor Angela Merkel is to meet the presidents of the three main EU institutions on Wednesday to discuss Germany's EU council presidency, which looks set to be dominated by the bloc's economic recovery following the coronavirus pandemic. During her first trip abroad since the beginning of the pandemic, Merkel will meet the presidents of the European Parliament, European Council, and European Commission: David Sassoli, Charles Michel and Ursula von der Leyen, respectively. Germany took over the EU Council presidency on July 1 and will hand it over to Portugal after six months. One of the biggest issues on their plate is the controversial multi-billion-euro coronavirus recovery plan.

----------

White House aides are considering undermining the Hong Kong dollar's peg to the greenback as part of efforts to punish China over its new security law in the city, a report said Wednesday. Bloomberg News said the idea from some officials to put a strain on the 37-year-old peg – possibly by limiting local banks' access to US dollars – was one of a number of measures flagged as Washington looks at ways to respond to the controversial law. However, it cited unnamed sources as saying the move had not been discussed at senior levels of the Trump administration, while analysts said such a measure was unlikely owing to the upheaval it would cause to global markets. Other measures being discussed included cancelling a US-Hong Kong extradition treaty and no longer cooperating with the city's police force, Bloomberg said.

----------

US President Donald Trump has formally started the withdrawal of the US from the World Health Organization, making good on threats over the UN body's response to the coronavirus, officials said Tuesday. The US is the largest financial contributor to the WHO – which leads the fight on global maladies from polio to measles to mental health – but it has increasingly been in Trump's crosshairs as the coronavirus takes a heavy toll. After threatening to suspend the USD400 million in annual US contributions and then announcing a withdrawal, Trump has formally informed UN Secretary-General Antonio Guterres that he has started the US pullout, a State Department spokesperson said. The withdrawal is effective in one year – July 6, 2021 – and Joe Biden, Trump's presumptive Democratic opponent, is virtually certain to stop it and stay in the WHO if he defeats Trump in the November election.

----------

BROKER RATING CHANGES

----------

CREDIT SUISSE REINITIATES WPP WITH 'UNDERPERFORM' - PRICE TARGET 565 PENCE

----------

RBC RAISES RIO TINTO TO 'SECTOR PERFORM' (UNDERPERFORM) - PRICE TARGET 4200 (3600) PENCE

----------

GOLDMAN CUTS RIO TINTO TO 'NEUTRAL' (BUY) - PRICE TARGET 4440 (4720) PENCE

----------

COMPANIES - FTSE 100

----------

Drugmaker AstraZeneca said Lynparza has been approved in the EU for patients with germline BRCA-mutated metastatic pancreatic cancer. The approval was based on results from the phase III Polo trial. "Today's approval opens the door to a new era of biomarker-led care for patients with metastatic pancreatic cancer in the EU, which has the highest incidence of any region globally," said Hedy Kindler, co-principal investigator of the POLO trial.

----------

Real estate investment trust SEGRO updated the market on rental collections from its UK portfolio associated with the UK quarterly payment date of June 24, saying that 93% of the GBP37 million of rent due was received. The company noted that GBP9 million of rent ordinarily due on the UK quarterly payment date has been re-profiled, mostly to be paid in the second half of 2020.

----------

COMPANIES - FTSE 250

----------

Aberdeen, Scotland-based transport company FirstGroup reported widened a pretax loss of GBP299.6 million for the year to the end of March compared with GBP97.9 million loss a year ago. FirstGroup explained that the loss reflects charges relating to the North American self-insurance provision, Greyhound impairment charges, restructuring and reorganisation costs and coronavirus-related charges. Trading trends prior to the pandemic were broadly similar throughout the year, the company noted, with industry cost pressures offset by revenue growth in First Student, First Transit and First Bus and management actions. Annual revenue, meanwhile, grew to GBP7.75 billion from GBP7.13 billion year-on-year. FirstGroup is not proposing to pay a dividend for financial 2020, but said it will continue to review the appropriate timing for restarting dividend payments.

----------

Property investment company CLS Holdings said vacancy rates have increased from the end of December 2019 levels due to refurbishments, acquired vacancy in the UK and some recent lease expiries across the portfolio. Since April 8, there have been 25 deals securing GBP3.2 million of annual rent, CLS said. The company said its balance sheet remains well-capitalised and robust. As at the end of June, CLS had cash of over GBP190 million, with a further GBP50 million in undrawn facilities.

----------

Lancashire, England-based Victrex said it had a solid start but weaker end to its third quarter as Covid-19 headwinds hurt performance. The polymer solutions provider reported a 12% drop in sales volume for the three months to the end of June to 805 tonnes, with revenue down 18% to GBP58.8 million, reflecting mix as a key driver. On a year-to-date basis, Victrex sales volume of 2,797 tonnes was broadly in line with the prior year's 2,811 tonnes. Year-to-date revenue stands at GBP210.3 million, down 3% compared to GBP217.8 million a year prior. Looking ahead, Victrex said with lower production levels and a weak product mix will hurt margins in the second half and in financial 2021.

----------

COMPANIES - MAIN MARKET AND AIM

----------

Boohoo said it is launching an immediate independent review of its UK supply chain, led by Alison Levitt QC. The fashion retailer said it is also accelerating its independent third party supply chain review with ethical audit and compliance specialists Verisio and Bureau Veritas. In addition, boohoo said it will be making an initial commitment to invest an incremental GBP10 million to eradicate supply chain malpractice. The move comes after Next and ASOS have dropped boohoo clothing from their websites after claims that the fast-fashion retailer sold clothes made in factories where staff were paid less than the minimum wage and worked in poor conditions. boohoo has had more than GBP1 billion wiped from its share value in the past two days after an article in the Sunday Times newspaper alleged that workers in a Leicester factory making clothes destined for boohoo were being paid as little as GBP3.50 an hour.

----------

COMPANIES - GLOBAL

----------

Intel Corp's Mobileye and transportation operator Willer are to collaborate on the launch of an autonomous robotaxi service in Japan and Southeast Asia, Intel said. Willer, which is among the largest transportation operators in Japan, Taiwan, and the southeast Asia region, will work with Intel on the testing and deployment of autonomous transportation. The collaboration will start in Japan, with the transportation solutions to be based on Mobileye's automated vehicle technology. Mobileye develops "computer vision and machine learning, data analysis, localisation and mapping for advanced driver-assistance systems and automated driving". The companies are planning to start testing their robotaxis on Japanese public roads starting 2021 before launching "fully self-driving ride-hailing and ride-sharing mobility services in 2023". The companies will also look for opportunities for similar services in Taiwan and elsewhere in southeast Asia.

----------

Wednesday's Shareholder Meetings

First Derivatives

Boku

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.